Evidence map›Paper›PMID 23765576›Full record

ReviewBioEssays : news and reviews in molecular, cellular and developmental biology2013

Phosphatidylinositol-3,4,5-trisphosphate: tool of choice for class I PI 3-kinases.

Rachel Schnur Salamon, Jonathan M Backer

Abstract readReview
In one paragraph

Review in BioEssays : news and reviews in molecular, cellular and developmental biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Role of Protein Kinase CK2 in Aberrant Lipid Metabolism in Cancer.Pharmaceuticals (Basel, Switzerland) · 2020
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rachel Schnur SalamonDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA.
Jonathan M Backer

Funding

Tumor Progression and MetastasisP01CA100324 · NCI · YESHIVA UNIVERSITY · PI CONDEELIS, JOHN S · 2003 to 2018
$30.0M
TRAINING PROGRAM IN CELLULAR &MOLEC. BIOLOGY &GENETICST32GM007491 · NIGMS · YESHIVA UNIVERSITY · PI QUERY, CHARLES C · 1985 to 2021
$17.0M
P85/P110 PI 3 KINASE--STRUCTURE/FUNCTION AND PHYSIOLOGYR01GM055692 · NIGMS · YESHIVA UNIVERSITY · PI BACKER, JONATHAN M. · 1997 to 2013
$4.4M
Physiology of Class III PI 3-kinase Signaling 2R01AG039632 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BACKER, JONATHAN M. · 2011 to 2015
$1.7M
Signaling by Vps34 in vertebratesF31AG040932 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SALAMON, RACHEL S · 2011 to 2012
$84k
NCI NIH HHS P01 CA 100324NCI NIH HHS P01 CA100324NIA NIH HHS 1F31 AG040932-01NIA NIH HHS F31 AG040932NIA NIH HHS R01 AG039632NIGMS NIH HHS 5T32 GM007491NIGMS NIH HHS GM55692NIGMS NIH HHS R01 GM055692NIGMS NIH HHS T32 GM007491
6 · The paper itself

Abstract

Class I PI 3-kinases signal by producing the signaling lipid phosphatidylinositol(3,4,5) trisphosphate, which in turn acts by recruiting downstream effectors that contain specific lipid-binding domains. The class I PI 3-kinases comprise four distinct catalytic subunits linked to one of seven different regulatory subunits. All the class I PI 3-kinases produce the same signaling lipid, PIP3, and the different isoforms have overlapping expression patterns and are coupled to overlapping sets of upstream activators. Nonetheless, studies in cultured cells and in animals have demonstrated that the different isoforms are coupled to distinct ranges of downstream responses. This review focuses on the mechanisms by which the production of a common product, PIP3, can produce isoform-specific signaling by PI 3-kinases.

Indexed as

Gene Expression Regulation, EnzymologicSignal TransductionAnimalsClass I Phosphatidylinositol 3-KinasesHumansIsoenzymesModels, AnimalPhosphatidylinositol PhosphatesProtein Interaction Domains and MotifsClass I Phosphatidylinositol 3-KinasesIsoenzymesphosphatidylinositol 3,4,5-triphosphatePhosphatidylinositol Phosphates

Identifiers

PMID23765576
PMCPMC3831874

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.